Kuehn Law, PLLC is investigating whether certain officers and directors of Rhythm Pharmaceuticals, Inc. breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. Long-term RYTM stockholders are encouraged to contact Justin Kuehn, Esq. by email at justin@kuehn.law or by phone at (833) 672-0814. The consultation and case are free with no obligation, and Kuehn Law pays all case costs without charging investor clients.
Rhythm Pharmaceuticals IncInvestigation for potential self-dealing and breach of fiduciary duties